Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1332

1.

[Thyroid storm and exacerbation of autoimmune hemolytic anemia following childbirth].

Sugisaki M, Ishizaki T, Iriuchishima H, Shimizu H, Yanagisawa K, Ogawa Y, Yokohama A, Saitoh T, Tsukamoto N, Handa H.

Rinsho Ketsueki. 2019;60(8):924-928. doi: 10.11406/rinketsu.60.924. Japanese.

PMID:
31484891
2.

Multifunctional S-Nitroso-N-acetylpenicillamine-Incorporated Medical-Grade Polymer with Selenium Interface for Biomedical Applications.

Mondal A, Douglass M, Hopkins SP, Singha P, Tran M, Handa H, Brisbois EJ.

ACS Appl Mater Interfaces. 2019 Sep 10. doi: 10.1021/acsami.9b10610. [Epub ahead of print]

PMID:
31483604
3.

Heparin-Free Extracorporeal Life Support Using Tethered Liquid Perfluorocarbon: A Feasibility and Efficacy Study.

Roberts TR, Harea GT, Singha P, Sieck KN, Beely BM, Wendorff DS, Choi JH, Ande S, Handa H, Batchinsky AI.

ASAIO J. 2019 Aug 22. doi: 10.1097/MAT.0000000000001055. [Epub ahead of print]

PMID:
31453831
4.

Estradiol accelerates liver regeneration through estrogen receptor α.

Tsugawa Y, Natori M, Handa H, Imai T.

Clin Exp Gastroenterol. 2019 Jul 22;12:331-336. doi: 10.2147/CEG.S214196. eCollection 2019.

5.

ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer.

Hashimoto S, Furukawa S, Hashimoto A, Tsutaho A, Fukao A, Sakamura Y, Parajuli G, Onodera Y, Otsuka Y, Handa H, Oikawa T, Hata S, Nishikawa Y, Mizukami Y, Kodama Y, Murakami M, Fujiwara T, Hirano S, Sabe H.

Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17450-17459. doi: 10.1073/pnas.1901765116. Epub 2019 Aug 9.

6.

Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study.

Usuki K, Handa H, Choi I, Yamauchi T, Iida H, Hata T, Ohwada S, Okudaira N, Nakamura K, Sakajiri S.

Int J Hematol. 2019 Jul 29. doi: 10.1007/s12185-019-02709-8. [Epub ahead of print]

PMID:
31359361
7.

Preeclampsia-Like Features and Partial Lactation Failure in Mice Lacking Cystathionine γ-Lyase-An Animal Model of Cystathioninuria.

Akahoshi N, Handa H, Takemoto R, Kamata S, Yoshida M, Onaka T, Ishii I.

Int J Mol Sci. 2019 Jul 17;20(14). pii: E3507. doi: 10.3390/ijms20143507.

8.

Versatile biomimetic medical device surface: hydrophobin coated, nitric oxide-releasing polymer for antimicrobial and hemocompatible applications.

Devine R, Singha P, Handa H.

Biomater Sci. 2019 Aug 1;7(8):3438-3449. doi: 10.1039/c9bm00469f. Epub 2019 Jul 3.

PMID:
31268063
9.

Molecular mechanisms of cereblon-based drugs.

Asatsuma-Okumura T, Ito T, Handa H.

Pharmacol Ther. 2019 Jun 14. pii: S0163-7258(19)30113-5. doi: 10.1016/j.pharmthera.2019.06.004. [Epub ahead of print] Review.

PMID:
31202702
10.

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D, Takamatsu H, Handa H, Ozaki S, Miki H, Takahashi T, Takeo T, Yamauchi T, Morishita T, Kosugi H, Shimizu K.

Int J Hematol. 2019 Jul;110(1):125-126. doi: 10.1007/s12185-019-02663-5.

PMID:
31119612
11.

Arginine induces IGF-1 secretion from the endoplasmic reticulum.

Tsugawa Y, Handa H, Imai T.

Biochem Biophys Res Commun. 2019 Jul 5;514(4):1128-1132. doi: 10.1016/j.bbrc.2019.05.044. Epub 2019 May 14.

PMID:
31101333
12.

Activin A: a novel urinary biomarker of renal impairment in multiple myeloma.

Iriuchishima H, Maeshima A, Takahashi S, Ishizaki T, Yokohama A, Tsukamoto N, Saitoh T, Murakami H, Handa H.

Biosci Rep. 2019 May 31;39(5). pii: BSR20190206. doi: 10.1042/BSR20190206. Print 2019 May 31.

13.

Cereblon Control of Zebrafish Brain Size by Regulation of Neural Stem Cell Proliferation.

Ando H, Sato T, Ito T, Yamamoto J, Sakamoto S, Nitta N, Asatsuma-Okumura T, Shimizu N, Mizushima R, Aoki I, Imai T, Yamaguchi Y, Berk AJ, Handa H.

iScience. 2019 May 31;15:95-108. doi: 10.1016/j.isci.2019.04.007. Epub 2019 Apr 9.

14.

Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma.

Ozaki S, Handa H, Saitoh T, Murakami H, Itagaki M, Asaoku H, Suzuki K, Isoda A, Matsumoto M, Sawamura M, Sunami K, Takezako N, Hagiwara S, Kuroda Y, Chou T, Nagura E, Shimizu K.

Ann Hematol. 2019 Jul;98(7):1703-1711. doi: 10.1007/s00277-019-03702-1. Epub 2019 May 2.

PMID:
31049648
15.

Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia.

Handa H, Nishimoto N, Inoue M, Yokohama A, Tsukamoto N, Saitoh T, Murakami H.

Hematol Oncol. 2019 Apr 16. doi: 10.1002/hon.2620. [Epub ahead of print] No abstract available.

PMID:
30990910
16.

Magnetically Promoted Rapid Immunofluorescence Staining for Frozen Tissue Sections.

Onishi T, Matsuda S, Nakamura Y, Kuramoto J, Tsuruma A, Sakamoto S, Suzuki S, Fuchimoto D, Onishi A, Chikaki S, Kaneko M, Kuwahata A, Sekino M, Yasuno H, Hanyu N, Kurita T, Takei H, Sakatani T, Taruno K, Nakamura S, Hayashida T, Jinno H, Kusakabe M, Handa H, Kameyama K, Kitagawa Y.

J Histochem Cytochem. 2019 Aug;67(8):575-587. doi: 10.1369/0022155419841023. Epub 2019 Apr 8.

PMID:
30958084
17.

Patients assigned to VGPR, PR, and SD in the IMWG response category are composed of heterogeneous population when assessed by the heavy/light chain assay.

Kamiya Y, Chou T, Murakami H, Handa H, Ozaki S, Shimazaki C, Fuchida SI, Okada J, Itoh J, Sugiyama S, Shimizu K.

Hematol Oncol. 2019 Aug;37(3):316-318. doi: 10.1002/hon.2611. Epub 2019 Apr 26. No abstract available.

PMID:
30938836
18.

Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-κB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia.

Tahara K, Koiso H, Osaki YH, Sekigami T, Yokohama A, Saitoh T, Tsukamoto N, Murakami H, Abe M, Handa H.

Acta Haematol. 2019;141(3):135-137. doi: 10.1159/000495741. Epub 2019 Feb 15. No abstract available.

19.

Zinc-oxide nanoparticles act catalytically and synergistically with nitric oxide donors to enhance antimicrobial efficacy.

Singha P, Workman CD, Pant J, Hopkins SP, Handa H.

J Biomed Mater Res A. 2019 Jul;107(7):1425-1433. doi: 10.1002/jbm.a.36657. Epub 2019 Mar 5.

PMID:
30737882
20.

[Recurrence of acquired factor V inhibitor after four years of remission].

Akashi N, Ogawa Y, Yanagisawa K, Osaki Y, Shimizu H, Ishizaki T, Inoue M, Murakami M, Souri M, Ichinose A, Handa H.

Rinsho Ketsueki. 2019;60(1):46-50. doi: 10.11406/rinketsu.60.46. Japanese.

PMID:
30726824
21.

Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D, Takamatsu H, Handa H, Ozaki S, Miki H, Takahashi T, Takeo T, Yamauchi T, Morishita T, Kosugi H, Shimizu K.

Int J Hematol. 2019 Apr;109(4):409-417. doi: 10.1007/s12185-019-02607-z. Epub 2019 Jan 31. Erratum in: Int J Hematol. 2019 Jul;110(1):125-126.

PMID:
30701467
22.

Correction to Tunable Nitric Oxide Release from S-Nitroso- N-acetylpenicillamine via Catalytic Copper Nanoparticles for Biomedical Applications.

Pant J, Goudie MJ, Hopkins SP, Brisbois EJ, Handa H.

ACS Appl Mater Interfaces. 2019 Jan 23;11(3):3627. doi: 10.1021/acsami.8b22363. Epub 2019 Jan 10. No abstract available.

PMID:
30629418
23.

Application of high-performance magnetic nanobeads to biological sensing devices.

Kabe Y, Sakamoto S, Hatakeyama M, Yamaguchi Y, Suematsu M, Itonaga M, Handa H.

Anal Bioanal Chem. 2019 Mar;411(9):1825-1837. doi: 10.1007/s00216-018-1548-y. Epub 2019 Jan 9. Review.

24.

Active Release of an Antimicrobial and Antiplatelet Agent from a Nonfouling Surface Modification.

Goudie MJ, Singha P, Hopkins SP, Brisbois EJ, Handa H.

ACS Appl Mater Interfaces. 2019 Jan 30;11(4):4523-4530. doi: 10.1021/acsami.8b16819. Epub 2019 Jan 16.

PMID:
30607929
25.

[Safety and management of adverse events of ixazomib/lenalidomide/dexamethasone therapy in Japanese patients with relapsed/refractory multiple myeloma].

Iida S, Izumi T, Aotsuka N, Komeno T, Ishida T, Sunami K, Handa H, Berg D, Kase Y, Soeda J.

Rinsho Ketsueki. 2018;59(11):2399-2407. doi: 10.11406/rinketsu.59.2399. Japanese.

PMID:
30531133
26.

Epithelial-specific histone modification of the miR-96/182 locus targeting AMAP1 mRNA predisposes p53 to suppress cell invasion in epithelial cells.

Handa H, Hashimoto A, Hashimoto S, Sugino H, Oikawa T, Sabe H.

Cell Commun Signal. 2018 Dec 4;16(1):94. doi: 10.1186/s12964-018-0302-6.

27.

Antithrombotic properties of hemofilter coated with polymer having a hydrophilic blood-contacting layer.

Tagaya M, Hara K, Takahashi S, Nagoshi S, Handa H, Okano S, Murataka T.

Int J Artif Organs. 2019 Feb;42(2):88-94. doi: 10.1177/0391398818815480. Epub 2018 Nov 29.

28.

Prognostic impact of trisomy 21 in follicular lymphoma.

Mitsui T, Yokohama A, Koiso H, Saito A, Toyama K, Shimizu H, Ishizaki T, Irisawa H, Takizawa M, Saitoh T, Murayama K, Matsumoto M, Handa H, Hirato J, Kojima M, Murakami H, Tsukamoto N.

Br J Haematol. 2019 Feb;184(4):570-577. doi: 10.1111/bjh.15664. Epub 2018 Nov 12.

PMID:
30417943
29.

Clinical impact of serum soluble SLAMF7 in multiple myeloma.

Ishibashi M, Soeda S, Sasaki M, Handa H, Imai Y, Tanaka N, Tanosaki S, Ito S, Odajima T, Sugimori H, Asayama T, Sunakawa M, Kaito Y, Kinoshita R, Kuribayashi Y, Onodera A, Moriya K, Tanaka J, Tsukune Y, Komatsu N, Inokuchi K, Tamura H.

Oncotarget. 2018 Oct 5;9(78):34784-34793. doi: 10.18632/oncotarget.26196. eCollection 2018 Oct 5.

30.

Two Types of Volatile Polyenes in the Brown Alga Sargassum thunbergii.

Lu SJ, Yosemoto S, Satomi D, Handa H, Akakabe Y.

J Oleo Sci. 2018;67(11):1463-1471. doi: 10.5650/jos.ess17276.

31.

Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.

Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S.

Blood Adv. 2018 Nov 13;2(21):2879-2889. doi: 10.1182/bloodadvances.2018019398.

32.

Structural features of two major nucleolar organizer regions (NORs), Nor-B1 and Nor-B2, and chromosome-specific rRNA gene expression in wheat.

Handa H, Kanamori H, Tanaka T, Murata K, Kobayashi F, Robinson SJ, Koh CS, Pozniak CJ, Sharpe AG, Paux E; International Wheat Genome Sequencing Consortium, Wu J, Nasuda S.

Plant J. 2018 Dec;96(6):1148-1159. doi: 10.1111/tpj.14094. Epub 2018 Oct 27.

PMID:
30238531
33.

Antibacterial 3D bone scaffolds for tissue engineering application.

Pant J, Sundaram J, Goudie MJ, Nguyen DT, Handa H.

J Biomed Mater Res B Appl Biomater. 2019 May;107(4):1068-1078. doi: 10.1002/jbm.b.34199. Epub 2018 Sep 19.

PMID:
30230685
34.

Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy.

Tsukamoto N, Yokohama A, Higuchi T, Mitsui T, Koiso H, Takizawa M, Shimizu H, Ishizaki T, Matsumoto M, Toyama K, Sakura T, Ogura H, Saitoh T, Ishida F, Murakami H, Tsushima Y, Handa H.

Int J Hematol. 2019 Jan;109(1):91-97. doi: 10.1007/s12185-018-2526-z. Epub 2018 Sep 10.

PMID:
30203253
35.

Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.

Kasamatsu T, Ozaki S, Saitoh T, Konishi J, Sunami K, Itagaki M, Asaoku H, Cho T, Handa H, Hagiwara S, Wakayama T, Negoro A, Takezako N, Harada N, Kuroda Y, Nakaseko C, Miyake T, Inoue N, Hata H, Shimazaki C, Ohno T, Kuroda J, Murayama T, Kobayashi T, Abe M, Ishida T, Nagura E, Shimizu K.

Hematol Oncol. 2018 Dec;36(5):792-800. doi: 10.1002/hon.2559. Epub 2018 Sep 19.

PMID:
30176173
36.

Clear cell myoepithelial carcinoma involving vestibule and alveolus: A rare case report with review of literature.

Gupta AA, Khare P, Jain M, Handa H.

J Oral Maxillofac Pathol. 2018 May-Aug;22(2):245-248. doi: 10.4103/jomfp.JOMFP_10_18.

37.

3D-measurement of tracheobronchial angles on inspiratory and expiratory chest CT in COPD: respiratory changes and correlation with airflow limitation.

Onoe R, Yamashiro T, Handa H, Azagami S, Matsuoka S, Inoue T, Miyazawa T, Mineshita M.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 10;13:2399-2407. doi: 10.2147/COPD.S165824. eCollection 2018.

38.

Shifting the limits in wheat research and breeding using a fully annotated reference genome.

International Wheat Genome Sequencing Consortium (IWGSC); IWGSC RefSeq principal investigators:, Appels R, Eversole K, Feuillet C, Keller B, Rogers J, Stein N; IWGSC whole-genome assembly principal investigators:, Pozniak CJ, Stein N, Choulet F, Distelfeld A, Eversole K, Poland J, Rogers J, Ronen G, Sharpe AG; Whole-genome sequencing and assembly:, Pozniak C, Ronen G, Stein N, Barad O, Baruch K, Choulet F, Keeble-Gagnère G, Mascher M, Sharpe AG, Ben-Zvi G, Josselin AA; Hi-C data-based scaffolding:, Stein N, Mascher M, Himmelbach A; Whole-genome assembly quality control and analyses:, Choulet F, Keeble-Gagnère G, Mascher M, Rogers J, Balfourier F, Gutierrez-Gonzalez J, Hayden M, Josselin AA, Koh C, Muehlbauer G, Pasam RK, Paux E, Pozniak CJ, Rigault P, Sharpe AG, Tibbits J, Tiwari V; Pseudomolecule assembly:, Choulet F, Keeble-Gagnère G, Mascher M, Josselin AA, Rogers J; RefSeq genome structure and gene analyses:, Spannagl M, Choulet F, Lang D, Gundlach H, Haberer G, Keeble-Gagnère G, Mayer KFX, Ormanbekova D, Paux E, Prade V, Šimková H, Wicker T; Automated annotation:, Choulet F, Spannagl M, Swarbreck D, Rimbert H, Felder M, Guilhot N, Gundlach H, Haberer G, Kaithakottil G, Keilwagen J, Lang D, Leroy P, Lux T, Mayer KFX, Twardziok S, Venturini L; Manual gene curation:, Appels R, Rimbert H, Choulet F, Juhász A, Keeble-Gagnère G; Subgenome comparative analyses:, Choulet F, Spannagl M, Lang D, Abrouk M, Haberer G, Keeble-Gagnère G, Mayer KFX, Wicker T; Transposable elements:, Choulet F, Wicker T, Gundlach H, Lang D, Spannagl M; Phylogenomic analyses:, Lang D, Spannagl M, Appels R, Fischer I; Transcriptome analyses and RNA-seq data:, Uauy C, Borrill P, Ramirez-Gonzalez RH, Appels R, Arnaud D, Chalabi S, Chalhoub B, Choulet F, Cory A, Datla R, Davey MW, Hayden M, Jacobs J, Lang D, Robinson SJ, Spannagl M, Steuernagel B, Tibbits J, Tiwari V, van Ex F, Wulff BBH; Whole-genome methylome:, Pozniak CJ, Robinson SJ, Sharpe AG, Cory A; Histone mark analyses:, Benhamed M, Paux E, Bendahmane A, Concia L, Latrasse D; BAC chromosome MTP IWGSC–Bayer Whole-Genome Profiling (WGP) tags:, Rogers J, Jacobs J, Alaux M, Appels R, Bartoš J, Bellec A, Berges H, Doležel J, Feuillet C, Frenkel Z, Gill B, Korol A, Letellier T, Olsen OA, Šimková H, Singh K, Valárik M, van der Vossen E, Vautrin S, Weining S; Chromosome LTC mapping and physical mapping quality control:, Korol A, Frenkel Z, Fahima T, Glikson V, Raats D, Rogers J; RH mapping:, Tiwari V, Gill B, Paux E, Poland J; Optical mapping:, Doležel J, Číhalíková J, Šimková H, Toegelová H, Vrána J; Recombination analyses:, Sourdille P, Darrier B; Gene family analyses:, Appels R, Spannagl M, Lang D, Fischer I, Ormanbekova D, Prade V; CBF gene family:, Barabaschi D, Cattivelli L; Dehydrin gene family:, Hernandez P, Galvez S, Budak H; NLR gene family:, Steuernagel B, Jones JDG, Witek K, Wulff BBH, Yu G; PPR gene family:, Small I, Melonek J, Zhou R; Prolamin gene family:, Juhász A, Belova T, Appels R, Olsen OA; WAK gene family:, Kanyuka K, King R; Stem solidness (SSt1) QTL team:, Nilsen K, Walkowiak S, Pozniak CJ, Cuthbert R, Datla R, Knox R, Wiebe K, Xiang D; Flowering locus C (FLC) gene team:, Rohde A, Golds T; Genome size analysis:, Doležel J, Čížková J, Tibbits J; MicroRNA and tRNA annotation:, Budak H, Akpinar BA, Biyiklioglu S; Genetic maps and mapping:, Muehlbauer G, Poland J, Gao L, Gutierrez-Gonzalez J, N'Daiye A; BAC libraries and chromosome sorting:, Doležel J, Šimková H, Číhalíková J, Kubaláková M, Šafář J, Vrána J; BAC pooling, BAC library repository, and access:, Berges H, Bellec A, Vautrin S; IWGSC sequence and data repository and access:, Alaux M, Alfama F, Adam-Blondon AF, Flores R, Guerche C, Letellier T, Loaec M, Quesneville H; Physical maps and BAC-based sequences:; 1A BAC sequencing and assembly:, Pozniak CJ, Sharpe AG, Walkowiak S, Budak H, Condie J, Ens J, Koh C, Maclachlan R, Tan Y, Wicker T; 1B BAC sequencing and assembly:, Choulet F, Paux E, Alberti A, Aury JM, Balfourier F, Barbe V, Couloux A, Cruaud C, Labadie K, Mangenot S, Wincker P; 1D, 4D, and 6D physical mapping:, Gill B, Kaur G, Luo M, Sehgal S; 2AL physical mapping:, Singh K, Chhuneja P, Gupta OP, Jindal S, Kaur P, Malik P, Sharma P, Yadav B; 2AS physical mapping:, Singh NK, Khurana J, Chaudhary C, Khurana P, Kumar V, Mahato A, Mathur S, Sevanthi A, Sharma N, Tomar RS; 2B, 2D, 4B, 5BL, and 5DL IWGSC–Bayer Whole-Genome Profiling (WGP) physical maps:, Rogers J, Jacobs J, Alaux M, Bellec A, Berges H, Doležel J, Feuillet C, Frenkel Z, Gill B, Korol A, van der Vossen E, Vautrin S; 3AL physical mapping:, Gill B, Kaur G, Luo M, Sehgal S; 3DS physical mapping and BAC sequencing and assembly:, Bartoš J, Holušová K, Plíhal O; 3DL BAC sequencing and assembly:, Clark MD, Heavens D, Kettleborough G, Wright J; 4A physical mapping, BAC sequencing, assembly, and annotation:, Valárik M, Abrouk M, Balcárková B, Holušová K, Hu Y, Luo M; 5BS BAC sequencing and assembly:, Salina E, Ravin N, Skryabin K, Beletsky A, Kadnikov V, Mardanov A, Nesterov M, Rakitin A, Sergeeva E; 6B BAC sequencing and assembly:, Handa H, Kanamori H, Katagiri S, Kobayashi F, Nasuda S, Tanaka T, Wu J; 7A physical mapping and BAC sequencing:, Appels R, Hayden M, Keeble-Gagnère G, Rigault P, Tibbits J; 7B physical mapping, BAC sequencing, and assembly:, Olsen OA, Belova T, Cattonaro F, Jiumeng M, Kugler K, Mayer KFX, Pfeifer M, Sandve S, Xun X, Zhan B; 7DS BAC sequencing and assembly:, Šimková H, Abrouk M, Batley J, Bayer PE, Edwards D, Hayashi S, Toegelová H, Tulpová Z, Visendi P; 7DL physical mapping and BAC sequencing:, Weining S, Cui L, Du X, Feng K, Nie X, Tong W, Wang L; Figures:, Borrill P, Gundlach H, Galvez S, Kaithakottil G, Lang D, Lux T, Mascher M, Ormanbekova D, Prade V, Ramirez-Gonzalez RH, Spannagl M, Stein N, Uauy C, Venturini L; Manuscript writing team:, Stein N, Appels R, Eversole K, Rogers J, Borrill P, Cattivelli L, Choulet F, Hernandez P, Kanyuka K, Lang D, Mascher M, Nilsen K, Paux E, Pozniak CJ, Ramirez-Gonzalez RH, Šimková H, Small I, Spannagl M, Swarbreck D, Uauy C.

Science. 2018 Aug 17;361(6403). pii: eaar7191. doi: 10.1126/science.aar7191. Epub 2018 Aug 16.

PMID:
30115783
39.

Function and structural regulation of the carbon monoxide (CO)-responsive membrane protein PGRMC1.

Kabe Y, Handa H, Suematsu M.

J Clin Biochem Nutr. 2018 Jul;63(1):12-17. doi: 10.3164/jcbn.17-132. Epub 2018 Apr 11. Review.

40.

A novel CYCS mutation in the α-helix of the CYCS C-terminal domain causes non-syndromic thrombocytopenia.

Uchiyama Y, Yanagisawa K, Kunishima S, Shiina M, Ogawa Y, Nakashima M, Hirato J, Imagawa E, Fujita A, Hamanaka K, Miyatake S, Mitsuhashi S, Takata A, Miyake N, Ogata K, Handa H, Matsumoto N, Mizuguchi T.

Clin Genet. 2018 Dec;94(6):548-553. doi: 10.1111/cge.13423. Epub 2018 Sep 3.

PMID:
30051457
41.

Achieving Long-Term Biocompatible Silicone via Covalently Immobilized S-Nitroso- N-acetylpenicillamine (SNAP) That Exhibits 4 Months of Sustained Nitric Oxide Release.

Hopkins SP, Pant J, Goudie MJ, Schmiedt C, Handa H.

ACS Appl Mater Interfaces. 2018 Aug 15;10(32):27316-27325. doi: 10.1021/acsami.8b08647. Epub 2018 Aug 1.

PMID:
30028941
42.

Development of a Highly Sensitive Device for Counting the Number of Disease-Specific Exosomes in Human Sera.

Kabe Y, Suematsu M, Sakamoto S, Hirai M, Koike I, Hishiki T, Matsuda A, Hasegawa Y, Tsujita K, Ono M, Minegishi N, Hozawa A, Murakami Y, Kubo M, Itonaga M, Handa H.

Clin Chem. 2018 Oct;64(10):1463-1473. doi: 10.1373/clinchem.2018.291963. Epub 2018 Jul 18.

PMID:
30021922
43.

NQO1 inhibits the TLR-dependent production of selective cytokines by promoting IκB-ζ degradation.

Kimura A, Kitajima M, Nishida K, Serada S, Fujimoto M, Naka T, Fujii-Kuriyama Y, Sakamato S, Ito T, Handa H, Tanaka T, Yoshimura A, Suzuki H.

J Exp Med. 2018 Aug 6;215(8):2197-2209. doi: 10.1084/jem.20172024. Epub 2018 Jun 22.

44.

Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols.

Kato H, Fujita H, Akiyama N, Kimura SI, Hiramoto N, Hosono N, Takahashi T, Shigeno K, Minamiguchi H, Miyatake J, Handa H, Kanda Y, Yoshida M, Miyawaki S, Ohtake S, Naoe T, Kiyoi H, Matsumura I, Miyazaki Y; Japan Adult Leukemia Study Group.

Support Care Cancer. 2018 Dec;26(12):4187-4198. doi: 10.1007/s00520-018-4292-0. Epub 2018 Jun 2.

PMID:
29860713
45.

[Congenital factor V and factor VIII deficiency discovered in an elderly patient with abnormal bleeding after trauma].

Ogawa Y, Yanagisawa K, Uchiyama Y, Matsumoto A, Inoue M, Toyama K, Miyazawa Y, Matsumoto N, Handa H.

Rinsho Ketsueki. 2018;59(4):383-388. doi: 10.11406/rinketsu.59.383. Japanese.

PMID:
29743396
46.

Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.

Gotoh N, Saitoh T, Takahashi N, Kasamatsu T, Minato Y, Lobna A, Oda T, Hoshino T, Sakura T, Shimizu H, Takizawa M, Handa H, Yokohama A, Tsukamoto N, Murakami H.

Int J Hematol. 2018 Sep;108(3):246-253. doi: 10.1007/s12185-018-2464-9. Epub 2018 May 8.

PMID:
29737460
47.

Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients.

Nagano D, Araki T, Yanagisawa K, Ogawa Y, Gohda F, Uchiumi H, Handa H, Nakamura T, Yamamoto K.

Eur J Clin Pharmacol. 2018 Aug;74(8):1055-1060. doi: 10.1007/s00228-018-2464-y. Epub 2018 May 2.

PMID:
29721582
48.

Successful hemostatic management of major surgery for cervical spondylotic myelopathy in a patient with severe factor XI deficiency.

Ogawa Y, Yanagisawa K, Uchiyama Y, Akashi N, Mieda T, Iizuka H, Inoue M, Shizuka R, Murakami M, Matsumoto N, Handa H.

Int J Hematol. 2018 Oct;108(4):443-446. doi: 10.1007/s12185-018-2462-y. Epub 2018 Apr 30.

PMID:
29713955
49.

Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan.

Noguchi S, Nakaseko C, Nishiwaki K, Ogasawara H, Ohishi K, Tokuhira M, Noguchi M, Kimura H, Handa H, Mitani K, Miura M, Wakita H, Takahashi N; STAT study group.

Int J Hematol. 2018 Aug;108(2):176-183. doi: 10.1007/s12185-018-2459-6. Epub 2018 Apr 30.

PMID:
29713954
50.

Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma.

Higuchi H, Yamakawa N, Imadome KI, Yahata T, Kotaki R, Ogata J, Kakizaki M, Fujita K, Lu J, Yokoyama K, Okuyama K, Sato A, Takamatsu M, Kurosaki N, Alba SM, Azhim A, Horie R, Watanabe T, Kitamura T, Ando K, Kashiwagi T, Matsui T, Okamoto A, Handa H, Kuroda M, Nakamura N, Kotani A.

Blood. 2018 Jun 7;131(23):2552-2567. doi: 10.1182/blood-2017-07-794529. Epub 2018 Apr 22.

Supplemental Content

Support Center